Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Celgene’s Revlimid scores NICE approval in follicular lymphoma
New ‘chemotherapy-free’ treatment for patients with limited options
Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
Advisory committee voted 6-5 in favour of drug
Menlo slumps as itching drug fails mid-stage trial
Shares in US biotech closed down almost a third after announcement
Trial of Amgen, Servier’s heart failure drug clears interim check
Drug could become a $2bn product if approved
Articles
-
Policy and public health: all the decisions we can't seeJanuary was a bad month for healthcare in China
-
Can protein degraders unlock ‘undruggable’ drug targets?Exploring a new and exciting area of small-molecule drug discovery
-
BRIC marketsWhy these countries offer an opportunity for pharma despite a slowdown
-
Digital divergence Combining digital and pharma is proving less easy than previously thought
-
Novo Nordisk awakens its ‘Sleeping Beauty’Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott
Pharmaceutical Market Europe - February 2020
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
Ex-BMS exec jumps to Gilead to lead research group
Gilead appoints Michael Quigley to lead research team
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
Policy and public health: all the decisions we can't see
January was a bad month for healthcare in China
Featured jobs
-
Account Manager
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Director, Medical Education
-
Salary TBC
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Account Director, Healthcare Communications
-
Salary TBC
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account director
-
Competitive salary and bonus scheme
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Publications director
-
Competitive salary and bonus scheme
-
Account Manager (PR)
-
Great Benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director
-
£Competitive Salary
Subscribe to our email news alerts
- Immutep spikes on trial of its LAG-3 drug with Keytruda
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Coronavirus outbreak escalation could impact drug supply chain
- Researchers discover new antibiotic using AI
- Genital herpes vaccine candidate heads for human studies
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- AVENIR GLOBAL appoints global healthcare lead
- Bedrock Group bolsters team with three key appointments
- AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
- Menlo slumps as itching drug fails mid-stage trial
PMHub
infill healthcare communication
infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...
Latest intelligence
- The ALS patient journey
- Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
- Equipping your medical affairs teams with solutions to navigate the healthcare landscape
- Dr Tyler Ray, OPEN Health Medical Communications...
- Can protein degraders unlock ‘undruggable’ drug targets?
- Exploring a new and exciting area of small-molecule drug discovery...
Quick links
Infographics
